News

The Editorial Team of Kidney International would like to reassure our readership that we will continue to bring you high quality information throughout the COVID-19 pandemic to help all of us deal with the crisis and provide high quality care to our patients. We have a mechanism in place to rapidly review and arrive at publication decisions for papers on the kidney implications of COVID-19, and release these papers in an open access format within one week after acceptance. We believe the best way nephrologists can contribute to the fight against this disease is by arming ourselves with the best and most up-to-date data possible.

The Editors of Kidney International would also like to thank all of our Reviewers for their outstanding work in guiding the publication of high impact papers. We understand that for most of us now many of our academic activities have been curtailed as we focus our efforts on combating the virus. We apologize to our Authors for any delays encountered in the reviewing process for non-COVID-19-related articles. Normal turnaround time for Kidney International averages 14 days for all original manuscripts, and we will make every effort to maintain a short review process during this time of stress.

During the first quarter of 2020 the number of submitted manuscripts to Kidney International has increased by 15% and we are grateful to the authors for choosing to publish with us despite the pandemic. We are very much aware of the huge professional and personal difficulties Authors are facing, including the shut down of laboratories and the virtual stand-still of most clinical trials, and we will take these difficulties into account during the reviewing process.

Despite all of these challenges, The Editorial Team remains dedicated to the mission of Kidney International and we are proud to serve the kidney community and contribute, together with the International Society of Nephrology, to global kidney health.  We are especially interested in well-designed papers on COVID-19 that provide impactful information on mechanisms, treatment and management of patients with kidney disease and COVID19 from diverse backgrounds. We would like to emphasize that those manuscripts will be subject to the same standards as all original articles submitted to KI. We are happy to hear from our readership and will appreciate any suggestions of how we can help you manage during this crisis.